Company Filing History:
Years Active: 2023
Title: Martin Emanuele: Innovator in Gene Therapy
Introduction
Martin Emanuele is a notable inventor based in San Diego, California. He has made significant contributions to the field of gene therapy, particularly in the context of age-related eye diseases. His innovative work focuses on therapeutic agents that enhance the expression of the ELOVL2 gene.
Latest Patents
Emanuele holds a patent for "ELOVL2 constructs for human gene therapy." This patent discloses therapeutic agents capable of increasing the expression level of ELOVL2. Additionally, it describes agents that can reduce or slow an aging phenotype. The patent also outlines methods for treating age-related eye diseases or conditions by administering these therapeutic agents.
Career Highlights
Martin Emanuele is associated with Visgenx, Inc., where he continues to advance his research in gene therapy. His work is pivotal in developing treatments that address age-related conditions, showcasing his commitment to improving human health.
Collaborations
Emanuele collaborates with Christopher Chavez, contributing to the innovative environment at Visgenx, Inc. Their partnership enhances the potential for breakthroughs in gene therapy.
Conclusion
Martin Emanuele's contributions to gene therapy, particularly through his patent on ELOVL2 constructs, highlight his role as an innovator in the field. His work promises to impact the treatment of age-related eye diseases significantly.